Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FIT Untethered: Insulin Degludec and CSII in Exercising T1D Patients
NCT03838783Phase 4Unknown
- Sponsor
- LMC Diabetes & Endocrinology
- Start
- May 2018
- Primary completion
- Apr 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of insulin degludec in type 1 diabetes mellitus (T1D), sponsored by LMC Diabetes & Endocrinology. Status: unknown.
02
Drugs
insulin degludec
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT03838783.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03838783.